Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RVLP - RVL Pharmaceuticals plc

IEX Last Trade
0.482
-0.002   -0.415%

Share volume: 48,889
Last Updated: Tue 08 Aug 2023 09:56:44 PM CEST
Medicinal and Botanical Manufacturing : -0.98%

PREVIOUS CLOSE
CHG
CHG%
$0.48
0.00
-0.41%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
50%
Profitability 40%
Dept financing 18%
Liquidity 25%
Performance 75%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.48
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
111.406 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Medicinal and Botanical Manufacturing
Sector: Manufacturing

osmotica pharmaceutical is focused on drug delivery technologies with a special focus in neurology-based therapies. we have a portfolio of products in various stages of development focused on the treatment of movement disorders, such as ms and parkinson's disease. in addition, we utilize our well-established drug delivery technologies (including our osmodex technologies) and our expertise to develop drug candidates for partner companies.

Recent news